1.Streptomyces as host for heterologous protein production. It has aldready proven that Streptomyces is a good choice for heterologous protein production and can be an invaluable host for eukaryotic proteins. Some of these heterologous proteins are secreted as biologically active compounds in commercially significant yield using expression/secretion signals we have isolated (EP0851931A), they can easily be purified and have the same ...
Technology Cluster Sustainable Chemical Process, Technology Campuses Ghent and Aalst
Chemical & Biochemical Process Technology & Control (BioTeC+)
Scientific research in BioTeC+ concentrates on model based optimization and control of microbial conversion processes. The underlying motivation is that model based solutions to process optimization and control problems are superior in performance and robustness as ...
Chemische procestechniek Modelling of gas-solid chemical reactors. Bubble flow, heat transfer and conversion in fluidized bed reactors. Numerical analysis of the bifurcation behavior of non-linear systems. Catalytic reduction of NOx in automotive exhaust gases. Modelling of multistage separation processes. Computer-aided design of chemical processes: development of simulation programs. Energy integration in chemical processes.
Department of Chemical Engineering (CIT) KU Leuven
For more information about the research topics of the different research teams belonging to this department see: - Division for chemical engineering - Division for physical chemistry - Division for expertsystems and processanalysis - Research group Environmental Technology - Laboratory of Applied Rheology and Polymer Processing
Medicinal Chemistry (Rega Institute) KU Leuven
The interests of the Laboratory for Medicinal Chemistry lay in the field of peptide, nucleoside and oligonucleotide chemistry. New substances are synthesized, analyzed and evaluated for activity in vitro. In addition, molecular modeling, NMR and mass spectrometry facilities are available and these units perform supporting research.
- Development of nucleoside derivatives with antiviral (AIDS chemotherapy) and antitumoral ...